Anhui Huaren Health Pharmaceutical Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: CNE100005YT4
CNY
16.74
0.34 (2.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
4,507.94
3,780.44
3,245.21
2,325.58
1,919.45
1,513.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,507.94
3,780.44
3,245.21
2,325.58
1,919.45
1,513.22
Raw Material Cost
3,102.37
2,680.81
2,264.90
1,590.21
1,289.50
998.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
35.31
31.89
25.40
26.01
8.60
8.19
Selling and Distribution Expenses
1,145.58
920.50
750.52
626.17
506.39
431.81
Other Expenses
-0.71
-0.77
-2.12
-2.55
-0.84
-0.82
Total Expenditure (Excl Depreciation)
4,276.14
3,625.50
3,019.59
2,216.88
1,796.09
1,429.81
Operating Profit (PBDIT) excl Other Income
231.8
154.9
225.6
108.69999999999999
123.4
83.4
Other Income
36.29
35.13
18.71
13.83
9.85
3.41
Operating Profit (PBDIT)
573.95
423.14
458.01
336.60
190.88
138.21
Interest
35.31
31.89
25.40
26.01
8.60
8.19
Exceptional Items
-17.20
0.03
0.00
-0.04
0.00
-0.00
Gross Profit (PBDT)
1,405.57
1,099.64
980.31
735.37
629.95
515.22
Depreciation
316.16
239.93
217.87
216.34
59.28
52.81
Profit Before Tax
205.29
151.35
214.74
94.22
123.00
77.21
Tax
53.21
33.83
54.48
24.48
34.14
23.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
137.70
114.67
160.78
69.73
88.92
51.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
137.70
114.67
160.78
69.73
88.92
51.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
14.56
3.01
-0.52
0.01
-0.06
1.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
152.26
117.68
160.26
69.73
88.86
53.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,005.29
1,943.53
947.28
784.80
714.83
536.21
Earnings per share (EPS)
0.34
0.29
0.4
0.17
0.22
0.13
Diluted Earnings per share
0.34
0.29
0.4
0.17
0.22
0.13
Operating Profit Margin (Excl OI)
4.91%
3.92%
6.82%
4.58%
6.34%
5.42%
Gross Profit Margin
11.57%
10.35%
13.33%
13.35%
9.5%
8.59%
PAT Margin
3.05%
3.03%
4.95%
3.0%
4.63%
3.43%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 19.24% vs 16.49% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 29.40% vs -26.58% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 38.58% vs -11.68% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 10.66% vs 25.59% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Anhui Huaren Health Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,507.94
0
4,507.94
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,507.94
0
4,507.94
Raw Material Cost
3,102.37
0
3,102.37
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
35.31
0
35.31
Selling and Distribution Expenses
1,145.58
0
1,145.58
Other Expenses
-0.71
0.00
-0.71
Total Expenditure (Excl Depreciation)
4,276.14
0
4,276.14
Operating Profit (PBDIT) excl Other Income
231.80
0.00
231.80
Other Income
36.29
0
36.29
Operating Profit (PBDIT)
573.95
0
573.95
Interest
35.31
0
35.31
Exceptional Items
-17.20
0
-17.20
Gross Profit (PBDT)
1,405.57
0
1,405.57
Depreciation
316.16
0
316.16
Profit Before Tax
205.29
0
205.29
Tax
53.21
0
53.21
Provisions and contingencies
0
0
0.00
Profit After Tax
137.70
0
137.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
137.70
0
137.70
Share in Profit of Associates
0
0
0.00
Minority Interest
14.56
0
14.56
Other related items
0.00
0.00
0.00
Consolidated Net Profit
152.26
0
152.26
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,005.29
0
2,005.29
Earnings per share (EPS)
0.34
0
0.34
Diluted Earnings per share
0.34
0
0.34
Operating Profit Margin (Excl OI)
4.91%
0%
0.00
4.91%
Gross Profit Margin
11.57%
0%
0.00
11.57%
PAT Margin
3.05%
0%
0.00
3.05%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 450.79 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.24% vs 16.49% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 15.23 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 29.40% vs -26.58% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.77 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.58% vs -11.68% in Dec 2023

Annual - Interest
Interest 3.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.66% vs 25.59% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.91%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023